What's the Problem?
According to the U.S. Food & Drug Administration (FDA), this recall affects:
- Alaris™ System PC Unit Model 8000
- Alaris™ System PC Unit Model 8015
- Alaris™ Pump Module Model 8100
- Alaris™ Syringe Module Model 8110
- Alaris™ PCA Module Model 8120
- Alaris™ EtCO2 Module Model 8300
- Alaris™ SpO2 Module Model 8210 and Model 8220
- Alaris™ Auto ID Module Model 8600
These infusion pumps may be equipped with the following potentially defective hardware systems:
- Damaged Inter-Unit Interface (IUI) Connectors
- Broken elements on Alaris™ Pump Module platen
- Improperly secured PC unit Battery
- Dim LED Segment(s) on the Alaris™ modules
Three of these situations have been designated as Class I recalls, which means "there is a reasonable probability that the use of the product will cause serious adverse health consequences or death," FDA said. "One of the situations was designated as a Class II recall, which means use of the product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
This recall began on August 20, 2020.
Check out the other defective product liability cases.
Do I Have an Alaris Infusion Pump Recall Lawsuit?
The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Alaris Infusion Pump Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one was injured by a recalled infusion pump, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.